Cargando…

Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

OBJECTIVE: To evaluate the efficacy and safety of Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility. METHODS: This randomized, double-blinded, placebo-controlled clinical trial was carried out in the Department of Obstetrics and Gynecolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huayun, Wang, Songpo, Gao, Xiaohong, Wang, Guozeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813249/
https://www.ncbi.nlm.nih.gov/pubmed/35126605
http://dx.doi.org/10.1155/2022/7933611
_version_ 1784644807744815104
author Xu, Huayun
Wang, Songpo
Gao, Xiaohong
Wang, Guozeng
author_facet Xu, Huayun
Wang, Songpo
Gao, Xiaohong
Wang, Guozeng
author_sort Xu, Huayun
collection PubMed
description OBJECTIVE: To evaluate the efficacy and safety of Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility. METHODS: This randomized, double-blinded, placebo-controlled clinical trial was carried out in the Department of Obstetrics and Gynecology and the Department of Traditional Chinese Medicine (TCM). During the 3 menstrual cycle intervention periods, all subjects received 50 mg/day CC from day 5 until day 9 of the menstruation. If no ovulation, the amount of CC per cycle increased 50 mg/day until 150 mg/day. Participants in the experimental group received YSTLG, while participants in the control group received YSTLG placebo. The granules were orally taken from the end of menstruation until ovulation. When one leading follicle attained a diameter of 18 mm or more, 5000 U human chorionic gonadotropin (hCG) was given intramuscularly. The primary outcome measure was the ovulation rate, and follicular development was monitored by transvaginal ultrasound on the 10(th) day of the cycles until ovulation. Secondary outcome measures including the overall curative effect, endometrial thickness, and pregnancy outcomes were also compared between the two groups. RESULTS: The ovulation rate in the experimental group was higher than that in the control group (P < 0.05). Compared with the control group, the overall curative effect of the experimental group was better than that of the control group (P < 0.05), and the endometrial thickness in the ovulation phase was significantly thicker than that in the control group (P < 0.01). There was no significant difference in pregnancy rate and miscarriage rate between the experimental group and control group (P > 0.05). CONCLUSION: The combined YSTLG and CC used to treat anovulatory infertility can improve the ovulation rate without affecting endometrial thickness, which is efficacious and safe.
format Online
Article
Text
id pubmed-8813249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-88132492022-02-04 Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial Xu, Huayun Wang, Songpo Gao, Xiaohong Wang, Guozeng Evid Based Complement Alternat Med Research Article OBJECTIVE: To evaluate the efficacy and safety of Yushen Tongluo Granule (YSTLG) combined with clomiphene citrate (CC) in the treatment of anovulatory infertility. METHODS: This randomized, double-blinded, placebo-controlled clinical trial was carried out in the Department of Obstetrics and Gynecology and the Department of Traditional Chinese Medicine (TCM). During the 3 menstrual cycle intervention periods, all subjects received 50 mg/day CC from day 5 until day 9 of the menstruation. If no ovulation, the amount of CC per cycle increased 50 mg/day until 150 mg/day. Participants in the experimental group received YSTLG, while participants in the control group received YSTLG placebo. The granules were orally taken from the end of menstruation until ovulation. When one leading follicle attained a diameter of 18 mm or more, 5000 U human chorionic gonadotropin (hCG) was given intramuscularly. The primary outcome measure was the ovulation rate, and follicular development was monitored by transvaginal ultrasound on the 10(th) day of the cycles until ovulation. Secondary outcome measures including the overall curative effect, endometrial thickness, and pregnancy outcomes were also compared between the two groups. RESULTS: The ovulation rate in the experimental group was higher than that in the control group (P < 0.05). Compared with the control group, the overall curative effect of the experimental group was better than that of the control group (P < 0.05), and the endometrial thickness in the ovulation phase was significantly thicker than that in the control group (P < 0.01). There was no significant difference in pregnancy rate and miscarriage rate between the experimental group and control group (P > 0.05). CONCLUSION: The combined YSTLG and CC used to treat anovulatory infertility can improve the ovulation rate without affecting endometrial thickness, which is efficacious and safe. Hindawi 2022-01-27 /pmc/articles/PMC8813249/ /pubmed/35126605 http://dx.doi.org/10.1155/2022/7933611 Text en Copyright © 2022 Huayun Xu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xu, Huayun
Wang, Songpo
Gao, Xiaohong
Wang, Guozeng
Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title_full Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title_fullStr Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title_full_unstemmed Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title_short Efficacy of Yushen Tongluo Granule Combined with Clomiphene Citrate for Anovulatory Infertility: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
title_sort efficacy of yushen tongluo granule combined with clomiphene citrate for anovulatory infertility: a double-blind, randomized, placebo-controlled clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813249/
https://www.ncbi.nlm.nih.gov/pubmed/35126605
http://dx.doi.org/10.1155/2022/7933611
work_keys_str_mv AT xuhuayun efficacyofyushentongluogranulecombinedwithclomiphenecitrateforanovulatoryinfertilityadoubleblindrandomizedplacebocontrolledclinicaltrial
AT wangsongpo efficacyofyushentongluogranulecombinedwithclomiphenecitrateforanovulatoryinfertilityadoubleblindrandomizedplacebocontrolledclinicaltrial
AT gaoxiaohong efficacyofyushentongluogranulecombinedwithclomiphenecitrateforanovulatoryinfertilityadoubleblindrandomizedplacebocontrolledclinicaltrial
AT wangguozeng efficacyofyushentongluogranulecombinedwithclomiphenecitrateforanovulatoryinfertilityadoubleblindrandomizedplacebocontrolledclinicaltrial